e-Drug3D 1207 |
cas 51-41-2 |
CLASS CARDIOVASCULAR |
ROUTE (list) INJECTION INTRAVENOUS |
NATURAL MOLECULE (link) ATC code |
PK parameters Solubility SPARINGLY SOLUBLE IN WATER |
Target TARGET ADRENERGIC RECEPTORS PDB Ligand code = LNR (link to the list of PDB complexes) Download experimental 3D coordinates of LNR with added hydrogens |
DrugCentral Beta-1 adrenergic receptor UNIPROT P08588 ADRB1 Beta-2 adrenergic receptor UNIPROT P07550 ADRB2 |
Download SDF file | 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol Formula: Calculated chemical properties: MW 169.18 NB_atoms 12 XLogP 0.09 PSA 87.389 NB_HD 5 NB_HA 4 fsp3 0.25 Lipinski(0=no;1=yes) 1 |
FDA NDA 007513 (label) INN (NOREPINEPHRINE BITARTRATE) LEVOPHED (HOSPIRA) APPROVAL= AP YEAR= 1950 NEWMOLECULARENTITY NDA 008592 (pdf not found) INN (NOREPINEPHRINE BITARTRATE ; PROCAINE HYDROCHLORIDE ; PROPOXYCAINE HYDROCHLORIDE) RAVOCAINE AND NOVOCAIN W/ LEVOPHED (EASTMAN KODAK) APPROVAL= AP YEAR= 1952 DISCONTINUED NDA 040455 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (MEITHEAL) APPROVAL= AP YEAR= 2003 NDA 040462 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (HIKMA) APPROVAL= AP YEAR= 2003 NDA 040522 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (METRICS PHARM) APPROVAL= AP YEAR= 2004 DISCONTINUED NDA 040859 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (BAXTER HLTHCARE CORP) APPROVAL= AP YEAR= 2012 NDA 203662 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (HIKMA) APPROVAL= AP YEAR= 2018 NDA 210839 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (AMNEAL) APPROVAL= AP YEAR= 2018 NDA 211242 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (MYLAN LABS LTD) APPROVAL= AP YEAR= 2018 NDA 211359 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (SANDOZ) APPROVAL= AP YEAR= 2018 NDA 211382 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2020 NDA 211980 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (SUN PHARM) APPROVAL= AP YEAR= 2021 DISCONTINUED NDA 214313 (label) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE (BAXTER HLTHCARE CORP) APPROVAL= AP YEAR= 2021 NDA 214323 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (GLAND) APPROVAL= AP YEAR= 2021 NDA 214455 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (BRECKENRIDGE) APPROVAL= AP YEAR= 2021 NDA 214628 (label) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (LONG GROVE PHARMS) APPROVAL= AP YEAR= 2022 NDA 215700 (label) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE (INFORLIFE) APPROVAL= AP YEAR= 2022 NDA 216341 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2022 DISCONTINUED NDA 217575 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (CAPLIN) APPROVAL= AP YEAR= 2023 NDA 218758 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (RISING) APPROVAL= AP YEAR= 2024 NDA 219163 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (ASPIRO) APPROVAL= AP YEAR= 2025 NDA 219443 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (BIOCON PHARMA) APPROVAL= AP YEAR= 2025 NDA 219692 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE (SAGENT) APPROVAL= AP YEAR= 2025 NDA 218595 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (MSN) APPROVAL= AP YEAR= 2025 NDA 219924 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (ANTHEA PHARMA) APPROVAL= AP YEAR= 2025 NDA 216272 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE (NEPHRON) APPROVAL= AP YEAR= 2026 NDA 220483 (pdf not found) INN (NOREPINEPHRINE BITARTRATE) NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE (SAGENT) APPROVAL= AP YEAR= 2026 |
Other links: | |
e-Drug3D 1722 |
cas 23651-95-8 |
CLASS CARDIOVASCULAR |
ROUTE (list) ORAL |
ATC code |
PK parameters Tmax 2 HOUR Solubility SLIGHTLY SOLUBLE IN WATER |
Target TARGET DOPA-DECARBOXYLASE |
DrugCentral Adrenergic receptor UNIPROT P07550 ADRB2 |
Download SDF file | L-Tyrosine, beta,3-dihydroxy-, (betaR)- Formula: Calculated chemical properties: MW 212.18 NB_atoms 15 XLogP -1.79 PSA 117.983 NB_HD 5 NB_HA 6 fsp3 0.22 Lipinski(0=no;1=yes) 1 |
FDA NDA 203202 (label) INN (DROXIDOPA) NORTHERA (LUNDBECK NA LTD) APPROVAL= AP YEAR= 2014 NDA 211818 (pdf not found) INN (DROXIDOPA) DROXIDOPA (ZYDUS PHARMS) APPROVAL= AP YEAR= 2021 NDA 211652 (pdf not found) INN (DROXIDOPA) DROXIDOPA (LUPIN PHARMS) APPROVAL= AP YEAR= 2021 DISCONTINUED NDA 211726 (pdf not found) INN (DROXIDOPA) DROXIDOPA (ANNORA) APPROVAL= AP YEAR= 2021 NDA 211741 (pdf not found) INN (DROXIDOPA) DROXIDOPA (MSN PHARMS INC) APPROVAL= AP YEAR= 2021 NDA 212835 (pdf not found) INN (DROXIDOPA) DROXIDOPA (HIKMA) APPROVAL= AP YEAR= 2021 DISCONTINUED NDA 213033 (pdf not found) INN (DROXIDOPA) DROXIDOPA (BIONPHARMA) APPROVAL= AP YEAR= 2021 NDA 213162 (pdf not found) INN (DROXIDOPA) DROXIDOPA (TEVA PHARMS USA INC) APPROVAL= AP YEAR= 2021 DISCONTINUED NDA 213661 (pdf not found) INN (DROXIDOPA) DROXIDOPA (UPSHER SMITH LABS) APPROVAL= AP YEAR= 2021 DISCONTINUED NDA 213911 (pdf not found) INN (DROXIDOPA) DROXIDOPA (ALKEM LABS LTD) APPROVAL= AP YEAR= 2021 NDA 214017 (pdf not found) INN (DROXIDOPA) DROXIDOPA (SCIEGEN PHARMS) APPROVAL= AP YEAR= 2021 NDA 214384 (pdf not found) INN (DROXIDOPA) DROXIDOPA (SUN PHARM) APPROVAL= AP YEAR= 2021 NDA 214387 (pdf not found) INN (DROXIDOPA) DROXIDOPA (AUROBINDO PHARMA LTD) APPROVAL= AP YEAR= 2021 NDA 214391 (pdf not found) INN (DROXIDOPA) DROXIDOPA (JUBILANT CADISTA) APPROVAL= AP YEAR= 2021 NDA 214543 (pdf not found) INN (DROXIDOPA) DROXIDOPA (SOMERSET THERAPS LLC) APPROVAL= AP YEAR= 2021 NDA 215265 (pdf not found) INN (DROXIDOPA) DROXIDOPA (ADAPTIS) APPROVAL= AP YEAR= 2021 NDA 214217 (pdf not found) INN (DROXIDOPA) DROXIDOPA (CHARTWELL RX) APPROVAL= AP YEAR= 2022 DISCONTINUED |
Other links: | |
e-Drug3D 1817 |
cas 299-42-3 |
CLASS RESPIRATORY |
ROUTE (list) INTRAVENOUS |
NATURAL MOLECULE (link) | PK parameters t1/2 6 HOUR Solubility FREELY SOLUBLE IN WATER |
Target TARGET ALPHA ADRENERGIC RECEPTOR |
DrugCentral Beta-2 adrenergic receptor UNIPROT P07550 ADRB2 |
Download SDF file | Benzenemethanol, alpha-[(1S)-1-(methylamino)ethyl]-, (alphaR)- Formula: Calculated chemical properties: MW 165.23 NB_atoms 12 XLogP 1.33 PSA 32.155 NB_HD 2 NB_HA 2 fsp3 0.40 Lipinski(0=no;1=yes) 1 |
FDA NDA 208289 (label) INN (EPHEDRINE SULFATE) AKOVAZ (EXELA PHARMA) APPROVAL= AP YEAR= 2016 NDA 208609 (label) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (RENEW PHARMS) APPROVAL= AP YEAR= 2017 DISCONTINUED NDA 208943 (label) INN (EPHEDRINE SULFATE) CORPHEDRA (PH HEALTH) APPROVAL= AP YEAR= 2017 NDA 209784 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (SANDOZ) APPROVAL= AP YEAR= 2017 NDA 212932 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (AMNEAL) APPROVAL= AP YEAR= 2019 NDA 213407 (label) INN (EPHEDRINE SULFATE) EMERPHED (NEXUS) APPROVAL= AP YEAR= 2020 NDA 209646 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2020 NDA 212649 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (DR REDDYS) APPROVAL= AP YEAR= 2020 NDA 213994 (label) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (PH HEALTH) APPROVAL= AP YEAR= 2020 NDA 214334 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (HIKMA) APPROVAL= AP YEAR= 2020 NDA 213536 (label) INN (EPHEDRINE HYDROCHLORIDE) REZIPRES (DR REDDYS LABS SA) APPROVAL= AP YEAR= 2021 DISCONTINUED NDA 214579 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (EUGIA PHARMA) APPROVAL= AP YEAR= 2021 NDA 215825 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (XIROMED) APPROVAL= AP YEAR= 2022 NDA 216129 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (MANKIND PHARMA) APPROVAL= AP YEAR= 2022 NDA 216146 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (GLAND) APPROVAL= AP YEAR= 2022 NDA 214528 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (SAGENT PHARMS INC) APPROVAL= AP YEAR= 2023 NDA 217276 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2023 DISCONTINUED NDA 217721 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (HIKMA) APPROVAL= AP YEAR= 2024 NDA 219050 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (CAPLIN) APPROVAL= AP YEAR= 2024 NDA 218211 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (GLAND) APPROVAL= AP YEAR= 2025 NDA 218271 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2025 NDA 215593 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (CIVICA) APPROVAL= AP YEAR= 2025 DISCONTINUED NDA 216740 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (BAXTER HLTHCARE CORP) APPROVAL= AP YEAR= 2026 NDA 219991 (pdf not found) INN (EPHEDRINE SULFATE) EPHEDRINE SULFATE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2026 |
Other links: |